Breaking News, Financial News

Financial Report: Charles River Laboratories

PCS sales up 6% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories

1Q Revenues: $291.2 million (+2%)

1Q Earnings: $25.8 million (-3%)

Comments: Research Models and Services (RMS) sales were flat at $182.5 million in the quarter. Excluding foreign exchange, RMS sales increased 1%. Preclinical Services (PCS) sales were $108.7 million, up 6%, driven by increased sales to large biopharma and mid-tier clients, primarily as a result of continued market share gains.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters